Keys to success for foundation: industry clinical development collaborationsPublished: November 7, 2019
Clinical Trial Designs For Advanced Therapies
Brian Fiske joined The Michael J. Fox Foundation for Parkinson’s Research (MJFF) in 2004. As Senior Vice President, Research Programs, Brian co-manages a team of professionals who stay closely linked to the Parkinson’s community in order to develop an aggressive and innovative agenda for accelerating research and drug development for Parkinson’s disease. This ensures that MJFF priorities reflect and best serve the ultimate needs of patients. Brian regularly meets with academic and industry scientists around the world to identify promising ideas to support, providing troubleshooting and ongoing management of projects as they go forward. He currently oversees the teams focused on MJFF’s strategies for developing disease-modifying and symptomatic therapies for Parkinson’s patients. Brian earned an undergraduate degree in biology from Texas A&M University and a PhD in Neuroscience from the University of Virginia. After completing postdoctoral research at Columbia University, Brian spent several years as an editor for the prestigious scientific journal, Nature Neuroscience. He brings this broad experience and knowledge to the Foundation to help bring new treatments to people with Parkinson’s.DOI: 10.18609/cgti.2019.145
Citation: Cell & Gene Therapy Insights 2019; 5(11), 1391-1397.